期刊文献+

肥胖治疗研究的现状与展望 被引量:6

Present and future management of obesity
下载PDF
导出
摘要 慢性非感染性疾病已经成为威胁中国人健康的主要原因。肥胖是其中起重要作用,需积极治疗的因素之一。对肥胖病理意义的认识经历了由宏观至微观,由全身至局部、细胞乃至分子水平的深入过程。肥胖病人脂肪的积聚,并由脂肪细胞流向非脂肪细胞,产生非脂肪细胞脂质异位沉着,同时使得脂肪细胞内分泌功能发生紊乱是造成脂肪中毒作用及其严重后果的病理生理机制。温故而知新,正确评价肥胖治疗的方法,提供适宜的积极治疗选择,展望未来的治疗,强化控制体重达标将是一个十分广阔的研究领域。 Obesity has now replaced undernutrition and infectious diseases as the most significant contributor to ill health. Major advances have now been made in identifying the components of the homeostatic system that regulates body weight, including several genes responsible for animal and human obesity. A key element of the pathophysiological machanism of obesity is the 'lipotoxicity' and the disturbance in the fat cell hormone. We will provide further insight into the present management of obesity, and possibilities for new treatment.
作者 邹大进
出处 《药学服务与研究》 CAS CSCD 2002年第2期73-78,共6页 Pharmaceutical Care and Research
关键词 现状 展望 肥胖症 治疗 obesity lipotoxicity treatment
  • 相关文献

参考文献18

  • 1王文绢,王克安,李天麟,向红丁,马林茂,富振英,陈君石,刘尊永,白锦,冯晋光,金书香,李彦琴,秦汝莉,陈泓.中国成年人肥胖的流行特点研究:超重和肥胖的现患率调查[J].中华流行病学杂志,2001,22(2):129-132. 被引量:228
  • 2邹大进.实用临床肥胖病学[M].上海:中国医药科技出版社,1998.84.
  • 3Nagaretani H, Nakamura T, Funahashi T, et al. Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance[J]. Diabetes Care, 2001, 24(12): 2127.
  • 4史轶蘩,李光伟,朱禧星,罗邦尧,傅祖植,程桦,高鑫,邓洁英,诸骏仁,朱文玲,柯元南,戚文航,伍卫,范维琥,苏炳华,何清波.奥利司他对中国肥胖患者的疗效和安全性分析[J].中华内分泌代谢杂志,2001,17(6):383-387. 被引量:42
  • 5Richard L, Atkinson D. Guidelines for the initiation of obesity treatment [J]. J Nutr Biochem, 1998, 9(10): 546.
  • 6Heymsfield SB, Segal KR, Hauptman J, et al. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults [J]. Arch Intern Med, 2000, 160(9): 1321.
  • 7Philip W, James T, Arne A, et al. Effect of sibutramine of weight maintanance initiation of obesity treatment after weight loss: a randomized trial[J]. Lancet, 2000, 365(9248): 2119.
  • 8邹大进,王卓.食欲抑制型减肥药西布曲明[J].中国新药杂志,2002,11(3):200-203. 被引量:6
  • 9Zachary T, Bloomgarden E. New insights in obesity[J]. Diabetes Care, 2002, 25(4):789.
  • 10吴坚,邹大进.瘦素受体的研究进展[J].生理科学进展,2000,31(2):143-146. 被引量:33

二级参考文献38

  • 1中国社会科学院人口研究所.中国人口年鉴[M].北京:经济管理出版社,1993.154-155.
  • 2[1]Sahu A, Kalra SP. Neuropeptidegic regulation of feeding behavior-Neuropeptide Y. Trends Endocronol. Metab, 1993, 4 (2): 217
  • 3[2]Billington CJ, Briggs JE, Harker S et al. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol, 1994, 266 (6 pt 2): 1765
  • 4[3]Zang Y. Positional cloning of the mouse obese gene and its human homolgue. Nature, 1994, 372 (6505): 425.
  • 5[4]Schwartz MW, Baskin DG, Bukowski TR et al. Specificity of leptin action on elevated blood glucose and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes, 1996, 45 (4): 531
  • 6[5]Sainsbury A, Cusin I, Rohner JF et al. Adrenalectomy prevents the obesity syndrome produced by chronic neuropeptide Y infusion in normal rats. Diabetes, 1997,46 (2): 209
  • 7[6]Robner JE,Jeanrenaud E,Jeanrenaud B.Central nervous system and body weight regulation. Ann-Endocrinol-Paris, 1997, 58(2): 137
  • 8[1]Silverstone T.Appetite suppressants:a review[J].Drugs ,1992,43(6)∶820-836.
  • 9[2]Heal DJ,Prow MR,Gosden J,et al.A comparison of various antide pressant drugs demonstrates rapid desensitisation of alpha2-adrenoceptors exclus ively by sibutramine hydrochloride[J].Psychopharmacology,1992,107(4)∶497- 502.
  • 10[3]Luscombe GP,Hopcroft RH,Thomas PC,et al.The contribution of m etabolities to the rapid and potent down-regulation of rat cortical beta-adren oceptors by the putative antidepressant sibutramine hydrochloride[J].Neuroph armacology,1989,28(2)∶129-134.

共引文献355

同被引文献68

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部